Caxton Associates (New York)’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,074
| Closed | -$88.3K | – | 568 |
|
|
2024
Q1 | $88.3K | Buy |
+31,074
| New | +$88.3K | ﹤0.01% | 438 |
|
|
2023
Q2 | – | Sell |
-12,306
| Closed | -$26.2K | – | 610 |
|
|
2023
Q1 | $26.2K | Buy |
+12,306
| New | +$26.2K | ﹤0.01% | 474 |
|
|
2021
Q2 | – | Sell |
-39,128
| Closed | -$713K | – | 543 |
|
|
2021
Q1 | $713K | Buy |
+39,128
| New | +$713K | 0.06% | 90 |
|